Medy-Tox Inc. (KOSDAQ:086900)

Medy-Tox Revenue

Medy-Tox had revenue of 68.70B KRW in the quarter ending June 30, 2026, with 11.44% growth. This brings the company's total for the last twelve months to 251.08B, up 7.01% year-over-year. In the year 2025, Medy-Tox had annual revenue of 247.29B with 8.17% growth. That makes Medy-Tox the 17,914th largest company in the world by revenue and 912th in South Korea.

• Revenue (ttm): 251.08B
• Revenue Growth: +7.01%
• P/S Ratio: 1.64
• Revenue / Employee: 357.15M
• Employees: 703
• Market Cap: 412.04B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Foreign Country 152.57B 62.7%
• South Korea 90.72B 37.3%

Fiscal year ended Dec 31, 2025 See the full Medy-Tox breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	247.29B	18.67B	8.17%
Dec 31, 2024	228.62B	7.50B	3.39%
Dec 31, 2023	221.12B	26.02B	13.34%
Dec 31, 2022	195.10B	10.23B	5.53%
Dec 31, 2021	184.87B	44.04B	31.27%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error